quadraScope Venture Fund
Venture capitalActively deployingBoston · 2 people tracked
Investment thesis
quadraScope focuses on the emerging rejuvenation and longevity biotech market, investing in companies addressing the biological hallmarks of aging—including genomic instability, telomere attrition, epigenetic alterations, cellular senescence, and mitochondrial dysfunction. The firm invests across the drug development lifecycle, from preclinical research to clinical development stages, backing diverse therapeutic modalities including nanomedicines, cellular reprogramming, regenerative medicine, and lipid-based metabolic treatments that target the root biological causes of aging-related diseases.
Source: firm website, verified Aug 11, 2026.
Team · 2 people
from public directories
What they invest in
from 10 of 13 portfolio companiesBiotech ×8Longevity ×6Digital Health ×4AI & Machine Learning ×3Healthtech ×3Deep Tech ×1Medical Devices ×1Wellness & Fitness ×1
HQs:United States×5
Investments · 13 tracked
founders shown can be your intro pathHealthtechMiami, US
Agustin Fernandez Santana III(Executive Officer, Director)Jeffrey B. Madden(Executive Officer, Director)David Buchsbaum(Executive Officer)Frank Mattner(Director)
BoardWalter Schmidt(Director)
Alden Scientific offers an AI-powered platform that harmonizes, quality-controls, and aligns fragmented multi-omic, clinical, immune, and longitudinal biological datasets to make measurements comparable across studies, populations, and time.
AI & Machine LearningBiotechDigital Health
Co-investorsiSelect FundDeep FutureService Provider Capital
BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery.
BiotechHealthtechMedical Devices
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development.
AI & Machine LearningBiotechDeep TechLongevity
Dr. Peterson
Co-investorsBioGenerator VenturesMissouri Technology Corporation
Cosmica builds OrganAge™, a blood-based biomarker tool that scores biological aging across nine physiological systems, and an intervention engine that ranks foods, supplements, and activities by how they act on a person's aging-related genes.
BiotechDigital HealthLongevity
David Furman(Founder & Chief Executive Officer)Abhay Saini(Co-founder & Chief Operating Officer)Fei Wu(Chief Scientific Officer)
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)Owl CapitalAxial VC+1 more
A longevity and anti-aging medical clinic offering personalized programs (e.g.
Digital HealthLongevityWellness & FitnessMiami, US
Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.
BiotechHealthtechLongevityIrvine, US
Hans Keirstead(Chairman of the Board)
Co-investorsBold Capital PartnersJLSRemiges Ventures, Inc.
Co-investorsLauder PartnersMelnichek Investments
BiotechSyracuse, US
Guilherme Cherman Perdigao de Oliveira(Executive Officer, Director)Reason("CEO's full legal name is ""Reason""")Anthony Matthew Chow(Director)
BoardKelsey Moody(Director)
Co-investorsThynk Capital
Vincere develops therapeutics for age-related diseases such as Parkinson's and kidney disease, using a computational platform that combines human genetics, cellular network models, and in-silico biology to identify drug targets like USP30 for mitochondrial repair.
AI & Machine LearningBiotechLongevity
Co-investorsBeiersdorf Innovation FundBeresford VenturesDraper AssociatesPortal Innovations
Portfolio news
latest coverage across their companiesAlden Scientific · oncimmune.com · Jul 23, 2025
Frequently asked questions
- How many investments has quadraScope Venture Fund made?
- quadraScope Venture Fund has 13 tracked investments.
- What sectors does quadraScope Venture Fund focus on?
- quadraScope Venture Fund focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is quadraScope Venture Fund located?
- quadraScope Venture Fund is headquartered in Boston, US.
- Who does quadraScope Venture Fund co-invest with?
- quadraScope Venture Fund most often shares deals with Bold Capital Partners, BioGenerator Ventures, CRV (Charles River Ventures), among 17 tracked co-investors.
Media · Podcasts & interviews
from their channelLongevity Nation 2025
quadraScope Ventures
Mitochondrial dysfunction
quadraScope Ventures
Chronic inflammation
quadraScope Ventures
BioChange – transforming tissue regeneration
quadraScope Ventures
Maintaining mitochondrial health – interview with Dr. Behrouz, co-founder & CEO @ Vincere Bio
quadraScope Ventures
Key trends in longevity science and market – 2024 Longevity Nation Conference
quadraScope Ventures
Images
Co-investors · 2
Cyberstarts is a venture firm focused on cybersecurity startups, backing founders who have overcome significant challenges and using a systematic process to identify urgent problems in the sector.
Canada's leading digital health venture capital firm investing in early-stage and high-growth technology companies transforming healthcare delivery across North America. The firm provides capital alongside hands-on operational guidance, commercial introductions, and go-to-market strategy support.
Firms observed investing alongside quadraScope Venture Fund, from public investor directories. Shared companies are the overlap with quadraScope Venture Fund's recorded portfolio.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
EQT Life Sciences, formerly LSP (Life Sciences Partners), is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.